N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis

Abstract Background Gastric cancer peritoneal metastasis is clinically challenging, given the limited treatment options and poor prognosis. The molecular mechanisms that precede gastric cancer peritoneal metastasis, known as the pre‐metastatic niche (PMN), and its relationship with N6‐methyladenosin...

Full description

Saved in:
Bibliographic Details
Main Authors: Song Li, Jianyuan Zhou, Shuang Wang, Qian Yang, Shulun Nie, Chunwang Ji, Xue Zhang, Shuhan Li, Xuanyu Zhou, Jiahui Chu, Xuehui Wu, Jianqiao Jiao, Ruitao Xu, Qian Xu, Miao Huang, Qiushi Wang, Liliang Dou, Qinqin Hu, Fan Jiang, Xin Dai, Zhaodi Nan, Xinyu Song, Di Zhang, Lian Liu
Format: Article
Language:English
Published: Wiley 2025-08-01
Series:Cancer Communications
Subjects:
Online Access:https://doi.org/10.1002/cac2.70034
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849233316018913280
author Song Li
Jianyuan Zhou
Shuang Wang
Qian Yang
Shulun Nie
Chunwang Ji
Xue Zhang
Shuhan Li
Xuanyu Zhou
Jiahui Chu
Xuehui Wu
Jianqiao Jiao
Ruitao Xu
Qian Xu
Miao Huang
Qiushi Wang
Liliang Dou
Qinqin Hu
Fan Jiang
Xin Dai
Zhaodi Nan
Xinyu Song
Di Zhang
Lian Liu
author_facet Song Li
Jianyuan Zhou
Shuang Wang
Qian Yang
Shulun Nie
Chunwang Ji
Xue Zhang
Shuhan Li
Xuanyu Zhou
Jiahui Chu
Xuehui Wu
Jianqiao Jiao
Ruitao Xu
Qian Xu
Miao Huang
Qiushi Wang
Liliang Dou
Qinqin Hu
Fan Jiang
Xin Dai
Zhaodi Nan
Xinyu Song
Di Zhang
Lian Liu
author_sort Song Li
collection DOAJ
description Abstract Background Gastric cancer peritoneal metastasis is clinically challenging, given the limited treatment options and poor prognosis. The molecular mechanisms that precede gastric cancer peritoneal metastasis, known as the pre‐metastatic niche (PMN), and its relationship with N6‐methyladenosine (m6A) modification remain unclear. Methods We used 87 resected gastric cancer tissues and 4 public datasets to explore the association between methyltransferase‐like 3 (METTL3) expression and gastric cancer peritoneal metastasis. Roles of m6A, exosomes, or macrophages in PMN formation were explored in immunocompetent mouse models through exosome treatments or macrophage modifications. Key genes and regulatory mechanisms were uncovered using mass spectrometry, RNA/miRNA sequencing, RNA‐immunoprecipitation, dual‐luciferase assays, and point mutations in the ras‐related protein Rab‐27A (RAB27A) in cells. Macrophage and T‐cell functions were assessed using enzyme‐linked immunosorbent assay, flow cytometry, and cytotoxicity assays. Results METTL3 overexpression in gastric cancer cells enhanced RAB27A translation by methylating its mRNA A502 base, facilitated by its m6A “reader” YTH N6‐methyladenosine RNA binding protein F1 (YTHDF1), and led to increased exosome biogenesis. The miRNA‐17‐92 cluster was enriched in METTL3‐overexpressed cell‐derived exosomes and targeted SRC kinase signaling inhibitor 1 (SRCIN1) to activate SRC proto‐oncogene, non‐receptor tyrosine kinase (SRC) signaling in peritoneal macrophages. Macrophage activation skewed cytokine production towards an immunosuppressive profile in the peritoneum, elevating the levels of interleukin (IL)‐10 and tumor necrosis factor (TNF) and reducing the levels of IL‐1 and IL‐6. These cytokine shifts inhibited T cell proliferation and cytotoxic activities, which created an immunosuppressive PMN and led to peritoneal metastasis. The association between METTL3, macrophages, and peritoneal metastasis was verified in clinical samples. Conclusions Our study identified an intricate m6A‐regulated mechanism of peritoneal PMN development that is mediated by exosome‐promoted macrophages. These insights into gastric cancer peritoneal metastasis offer promising directions for translational research.
format Article
id doaj-art-421e6d1541a347aeb6d444648cabd0ec
institution Kabale University
issn 2523-3548
language English
publishDate 2025-08-01
publisher Wiley
record_format Article
series Cancer Communications
spelling doaj-art-421e6d1541a347aeb6d444648cabd0ec2025-08-20T08:40:33ZengWileyCancer Communications2523-35482025-08-0145894196510.1002/cac2.70034N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasisSong Li0Jianyuan Zhou1Shuang Wang2Qian Yang3Shulun Nie4Chunwang Ji5Xue Zhang6Shuhan Li7Xuanyu Zhou8Jiahui Chu9Xuehui Wu10Jianqiao Jiao11Ruitao Xu12Qian Xu13Miao Huang14Qiushi Wang15Liliang Dou16Qinqin Hu17Fan Jiang18Xin Dai19Zhaodi Nan20Xinyu Song21Di Zhang22Lian Liu23Department of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Pharmacy Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaDepartment of Medical Oncology Qilu Hospital, Cheeloo College of Medicine, Shandong University Jinan Shandong P. R. ChinaAbstract Background Gastric cancer peritoneal metastasis is clinically challenging, given the limited treatment options and poor prognosis. The molecular mechanisms that precede gastric cancer peritoneal metastasis, known as the pre‐metastatic niche (PMN), and its relationship with N6‐methyladenosine (m6A) modification remain unclear. Methods We used 87 resected gastric cancer tissues and 4 public datasets to explore the association between methyltransferase‐like 3 (METTL3) expression and gastric cancer peritoneal metastasis. Roles of m6A, exosomes, or macrophages in PMN formation were explored in immunocompetent mouse models through exosome treatments or macrophage modifications. Key genes and regulatory mechanisms were uncovered using mass spectrometry, RNA/miRNA sequencing, RNA‐immunoprecipitation, dual‐luciferase assays, and point mutations in the ras‐related protein Rab‐27A (RAB27A) in cells. Macrophage and T‐cell functions were assessed using enzyme‐linked immunosorbent assay, flow cytometry, and cytotoxicity assays. Results METTL3 overexpression in gastric cancer cells enhanced RAB27A translation by methylating its mRNA A502 base, facilitated by its m6A “reader” YTH N6‐methyladenosine RNA binding protein F1 (YTHDF1), and led to increased exosome biogenesis. The miRNA‐17‐92 cluster was enriched in METTL3‐overexpressed cell‐derived exosomes and targeted SRC kinase signaling inhibitor 1 (SRCIN1) to activate SRC proto‐oncogene, non‐receptor tyrosine kinase (SRC) signaling in peritoneal macrophages. Macrophage activation skewed cytokine production towards an immunosuppressive profile in the peritoneum, elevating the levels of interleukin (IL)‐10 and tumor necrosis factor (TNF) and reducing the levels of IL‐1 and IL‐6. These cytokine shifts inhibited T cell proliferation and cytotoxic activities, which created an immunosuppressive PMN and led to peritoneal metastasis. The association between METTL3, macrophages, and peritoneal metastasis was verified in clinical samples. Conclusions Our study identified an intricate m6A‐regulated mechanism of peritoneal PMN development that is mediated by exosome‐promoted macrophages. These insights into gastric cancer peritoneal metastasis offer promising directions for translational research.https://doi.org/10.1002/cac2.70034exosomesgastric cancerN6‐methyladenosineperitoneal metastasispre‐metastatic niche
spellingShingle Song Li
Jianyuan Zhou
Shuang Wang
Qian Yang
Shulun Nie
Chunwang Ji
Xue Zhang
Shuhan Li
Xuanyu Zhou
Jiahui Chu
Xuehui Wu
Jianqiao Jiao
Ruitao Xu
Qian Xu
Miao Huang
Qiushi Wang
Liliang Dou
Qinqin Hu
Fan Jiang
Xin Dai
Zhaodi Nan
Xinyu Song
Di Zhang
Lian Liu
N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis
Cancer Communications
exosomes
gastric cancer
N6‐methyladenosine
peritoneal metastasis
pre‐metastatic niche
title N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis
title_full N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis
title_fullStr N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis
title_full_unstemmed N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis
title_short N6‐methyladenosine‐regulated exosome biogenesis orchestrates an immunosuppressive pre‐metastatic niche in gastric cancer peritoneal metastasis
title_sort n6 methyladenosine regulated exosome biogenesis orchestrates an immunosuppressive pre metastatic niche in gastric cancer peritoneal metastasis
topic exosomes
gastric cancer
N6‐methyladenosine
peritoneal metastasis
pre‐metastatic niche
url https://doi.org/10.1002/cac2.70034
work_keys_str_mv AT songli n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT jianyuanzhou n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT shuangwang n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT qianyang n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT shulunnie n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT chunwangji n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT xuezhang n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT shuhanli n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT xuanyuzhou n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT jiahuichu n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT xuehuiwu n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT jianqiaojiao n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT ruitaoxu n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT qianxu n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT miaohuang n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT qiushiwang n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT liliangdou n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT qinqinhu n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT fanjiang n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT xindai n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT zhaodinan n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT xinyusong n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT dizhang n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis
AT lianliu n6methyladenosineregulatedexosomebiogenesisorchestratesanimmunosuppressivepremetastaticnicheingastriccancerperitonealmetastasis